« Previous
Next »
European Neuropsychopharmacology
Volume 19, Issue 9
, Pages 636-647
, September 2009
Amelioration of cognitive deficits and neurodegeneration by curcumin in rat model of sporadic dementia of Alzheimer's type (SDAT)
References
- . Ginkgo biloba affords dose-dependent protection against 6-hydroxydopamine-induced parkinsonism in rats: neurobehavioural, neurochemical and immunohistochemical evidences. J. Neurochem. 2005;93:94–104
- . Pharmacology of Curcuma longa (Review). Planta Med. 1991;57:1–7
- . Alzheimer's disease as a disorder of mechanisms underlying structural brain self-organization (Review). Neuroscience. 2001;102:723–765
- . The aging paradox: free radical theory of aging (Review). Exp. Gerontol. 1999;34:293–303
- . Neuroprotective and anti-ageing effects of curcumin in aged rat brain regions. Biogerontology. 2006;7:81–89
- . Effect of naringenin on intracerebroventricular streptozotocin-induced cognitive deficits in rat: a behavioral analysis. Pharmacology. 2006;78:193–197
- . On the antioxidant mechanism of curcumin: classical methods are needed to determine antioxidant mechanism and activity (Review). Org. Lett. 2000;2:2841–2843
- . Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer's disease (Review). J. Pharmacol. Exp. Ther. 2008;326:196–208
- . Protective effect of curcumin, the active principle of turmeric (Curcuma longa) in haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes in rat brain. Pharmacol. Biochem. Behav. 2008;88:511–522
- . Spatial learning deficit and reduced hippocampal ChAT activity in rats after an ICV injection of streptozotocin. Pharmacol. Biochem. Behav. 1993;44:491–494
- . Proteomics: a new approach to investigate oxidative stress in Alzheimer's disease brain. Brain Res. 2004;1000:1–7
- . Purification and characterization of the flavoenzyme glutathione reductase from rat liver. J. Biol. Chem. 1975;250:5475–5480
- . Dose dependence and therapeutic window for the neuroprotective effects of curcumin in thromboembolic model of rat. Behav. Brain Res. 2008;193:289–297
- . Metabolism and functions of glutathione in brain (Review). Prog. Neurobiol. 2000;62:649–671
- . Glutathione metabolism in brain metabolic interaction between astrocytes and neurons in the defense against reactive oxygen species. Eur. J. Biochem. 2000;267:4912–4916
- . Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol. 1990;186:407–421
- . The colorimetric determination of phosphorus. J. Biol. Chem. 1925;66:375–400
- . A rapid radiochemical method for the determination of choline acetyltransferase. J. Neurochem. 1975;24:407–409
- . The cholinergic hypothesis of Alzheimer's disease: a review of progress (Review). J. Neurol. Neurosurg. Psychiatry. 1999;66:137–147
- . Phenolic anti-inflammatory antioxidant reversal of Abeta-induced cognitive deficits and neuropathology. Neurobiol. Aging. 2001;22:993–1005
- . Cognitive impairment of rats caused by oxidative stress and aging, and its prevention by Vitamin E. Ann. N. Y. Acad. Sci. 2002;959:272–284
- . Apolipoprotein E polymorphism and Alzheimer disease: the Indo–US Cross-National Dementia Study. Arch. Neurol. 2000;57:824–830
- . Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment (Review). Drugs Aging. 2001;18:685–716
- . Oxygen radicals and nervous system (Review). Trends Neurosci. 1985;8:22–26
- . Free radicals, other reactive species and disease. In: Halliwell B, Gutteridge JMC editor. Free Radicals in Biology and Medicine. 3rd ed. Oxford: Clarendon Press; 1999;p. 617–783
- . Cl-ATPase and Na+/K(+)-ATPase activities in Alzheimer's disease brains. Neurosci. Lett. 1998;254:141–144
- . Inhibition of the neuronal insulin receptor causes Alzheimer-like disturbances in oxidative/energy brain metabolism and in behavior in adult rats. Ann. N.Y. Acad. Sci. 1999;893:301–303
- . Long-term abnormalities in brain glucose/energy metabolism after inhibition of the neuronal insulin receptor: implication of tau-protein. J. Neural Transm., Suppl. 2007;72:195–202
- . Long-term effects of corticosterone on behavior, oxidative and energy metabolism of parietotemporal cerebral cortex and hippocampus of rats: comparison to intracerebroventricular streptozotocin. J. Neural Transm. 2008;115:1241–1249
- . Coenzyme Q10 modulates cognitive impairment against intracerebroventricular injection of streptozotocin in rats. Behav. Brain Res. 2006;171:9–16
- . Selenium-induced alteration of lipids, lipid peroxidation, and thiol group in circadian rhythm centers of rat. Biol. Trace Elem. Res. 2002;90:203–214
- . Modulation of mouse cerebral Na+,K(+)-ATPase activity by oxygen free radicals. Neuroreport. 1995;7:333–337
- . Ferrous ion oxidation in the presence of xylenol orange for detection of lipid hydroperoxide in low density lipoprotein. Anal. Biochem. 1992;202:384–389
- . Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite. Pharmacology. 1974;11:151–169
- . Prevention of cognitive impairments and neurodegeneration by Khamira Abresham Hakim Arshad Wala. J. Ethnopharmacol. 2006;108:68–73
- . Curcumin attenuates diabetic encephalopathy in rats: behavioral and biochemical evidences. Eur. J. Pharmacol. 2007;576:34–42
- . Effect of curcumin on intracerebroventricular colchicine-induced cognitive impairment and oxidative stress in rats. J. Med. Food. 2007;10:486–494
- . Oxygen radical scavenging activity of curcumin. Int. J. Pharm. 1990;58:237–240
- . Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol. 1990;186:464–478
- . The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J. Neurosci. 2001;21:8370–8377
- . Modulation of human multidrug-resistance MDR-1 gene by natural curcuminoids. BMC Cancer. 2004;4:13
- . Reversal of age-related learning deficits and brain oxidative stress in mice with superoxide dismutase/catalase mimetics. Proc. Natl. Acad. Sci. U. S. A. 2001;100:8526–8531
- . Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951;193:265–275
- Maher, P., Akaishi, T., Schubert, D. and Abe, K., in press. A pyrazole derivative of curcumin enhances memory. Neurobiol. Aging.
- . Effect of photo-irradiated curcumin treatment against oxidative stress in streptozotocin-induced diabetic rats. J. Med. Food. 2005;8:251–255
- . Increased susceptibility of Alzheimer's disease temporal cortex to oxygen free radical-mediated processes. Free Radic. Biol. Med. 1997;23:183–190
- . Glutathione metabolism and its selective modification. J. Biol. Chem. 1988;263:17205–17208
- . Developments of a water-maze procedure for studying spatial learning in the rat. J. Neurosci. Methods. 1984;11:47–60
- . Curry consumption and cognitive function in the elderly. Am. J. Epidemiol. 2006;164:898–906
- . Curcumin has potent anti-amyloidogenic effects for Alzheimer's beta-amyloid fibrils in vitro. J. Neurosci. Res. 2004;75:742–750
- . The rat brain in stereotaxic coordinates. 2nd ed.. Sydney: Change to Academic Press; 1986;
- . In vivo protective effects of ferulic acid ethyl ester against amyloid-beta peptide 1-42-induced oxidative stress. J. Neurosci. Res. 2006;84:418–426
- . Cognitive performance and biochemical markers in septum, hippocampus and striatum of rats after an i.c.v. injection of streptozotocin: a correlation analysis. Behav. Brain Res. 1999;102:73–88
- . Possible antioxidant mechanism in melatonin reversal of aging and chronic ethanol-induced amnesia in plus-maze and passive avoidance memory tasks. Free Radic. Biol. Med. 2001;30:595–602
- . Benefits from dietary polyphenols for brain aging and Alzheimer's disease. Neurochem. Res. 2008;33:2390–4000
- . Regulation of the sodium pump: how and why?. Trends Biochem. Sci. 1987;2:483–487
- . Alzheimer's disease: genes, proteins, and therapy (Review). Physiol. Rev. 2001;81:741–766
- . Intracerebroventricular injection of streptozotocin in rats produces both oxidative stress in the brain and cognitive impairment. Life Sci. 2001;68:1021–1029
- . Curcumin: the story so far (Review). Eur. J. Cancer. 2005;41:1955–1968
- . Free radical scavenging activity of curcuminoids. Arzneimittelforschung. 1996;46:169–171
- . Ferulic acid ethyl ester protects neurons against amyloid beta-peptide (1–42)-induced oxidative stress and neurotoxicity: relationship to antioxidant activity. J. Neurochem. 2005;92:749–758
- . Free radicals, antioxidant enzymes, and carcinogenesis. Free Radic. Biol. Med. 1990;8:583–599
- . Catecholamines and the brain microsomal Na, K-adenosinetriphosphatase-I. Protection against lipoperoxidative damage. Biochem. Pharmacol. 1981;30:427–432
- . Reduced brain antioxidant capacity in rat models of betacytotoxic-induced experimental sporadic Alzheimer's disease and diabetes mellitus. Neurochem. Res. 2007;32:1709–1717
- . Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: Applications to mammalian blood and other tissues. Anal. Biochem. 1969;27:502–522
- . Effect of sulfhydryl reagent on peroxidation in microsome. Arch. Biochem. Biophys. 1967;260:521–531
- . Manganese complexes of curcumin and its derivatives: evaluation for the radical scavenging ability and neuroprotective activity. Free Radic. Biol. Med. 2003;35:1632–1644
- . Automated assays for superoxide dismutase, catalase, glutathione peroxidase and glutathione reductase activity. Anal. Biochem. 1990;184:193–199
- . Ageing and the free radical theory (Review). Respir. Physiol. 2001;128:379–391
- . Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J. Biol. Chem. 2005;280:5892–5901
- . Critical evaluation of the free radical theory of aging. A proposal for the oxidative stress hypothesis. Ann. N.Y. Acad. Sci. 1996;786:1–11
- . Oxidative imbalance in Alzheimer's disease (Review). Mol. Neurobiol. 2005;31:205–217
☆ This research was supported by AYUSH grant, ministry of health and family Welfare, Goverment of India, New Delhi.
PII: S0924-977X(09)00049-2
doi: 10.1016/j.euroneuro.2009.02.002
© 2009 Elsevier B.V. and ECNP. All rights reserved.
« Previous
Next »
European Neuropsychopharmacology
Volume 19, Issue 9
, Pages 636-647
, September 2009
